Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16343 |
NRC-2694
|
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
NRC-2694 是表皮生长因子受体的有效拮抗剂,具抗增殖、有抗癌的活性。 | |||
T26625 |
AN-019
NRC-AN-019,NRC-019 |
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
AN-019 (NRC-019) 是一种 Bcr-Abl 激酶抑制剂, 具有抗肿瘤活性,可用于研究慢性粒细胞白血病(CML)和乳腺癌。 | |||
T71331 |
NRC-2694 dihydrochloride
|
||
NRC-2694 dihydrochloride is an epidermal growth factor receptor (EGFR) antagonist potentially for the treatment of solid tumors. | |||
T71332 |
NRC-2694 hydrochloride
|
||
NRC-2694 hydrochloride is an epidermal growth factor receptor (EGFR) antagonist potentially for the treatment of solid tumors. | |||
T81644 |
NRC-16
|
||
NRC-16为具有生物活性的肽,属于(杀侧耳素样阳离子AMP)类化合物。 | |||
T71330 |
Bexin-1
|
||
Bexin-1 is an inhibitor of Munc13-4 membrane binding which targets the Munc13-4 C2 domain-membrane interface, and inhibits ionomycin-stimulated ANF-EGFP secretion. | |||
T71985 |
ID110460002
|
||
ID110460002 is a novel μ,δ-Opioid Receptor Dual-Biased Agonist, Overcoming the Limitation of Prior Biased Agonist. |